Europe Amniotic Membrane Market – Industry Trends and Forecast to 2029

Market Analysis and Insights: Europe Amniotic Membrane Market

Europe amniotic membrane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.1% in the forecast period of 2022 to 2029 and is expected to reach USD 304.39 million by 2029 from USD 166.50 million in 2021.

The amniotic membrane, also known as the amnion, is the innermost layer of the placenta. It consists of a very thick basement membrane and an avascular stromal matrix. Amniotic membrane transplantation has been used as a graft or in the form of a dressing in various surgical specialties. Amniotic membrane transplantation is widely used in pterygium surgery, where the abnormal tissue from the corneal side is peeled off without damaging the underlying corneal tissue, and then the amniotic membrane tissue is transplanted there.

The Europe amniotic membrane market is growing in the forecast year due to the rise in the number of accidents, burn injuries, and trauma cases and also due to the rising adaptation of amniotic membrane transplantation in ophthalmology. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market. However, the limitations for the use of amniotic membranes and stringent government regulations may hamper the growth of the Europe amniotic membrane market in the forecast period.

The Europe amniotic membrane market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Amniotic Membrane Market Scope and Market Size

Europe amniotic membrane market is segmented into three notable segments which are based on the basis of product, application and end-user.

• On the basis of product, the Europe amniotic membrane market is segmented into a cryopreserved amniotic membrane, dehydrated amniotic membrane, and others. In 2022, the dehydrated amniotic membrane segment is expected to dominate the market due to the rising number of relatable products in the market and also a large number of beneficial effects of amniotic membranes.
• On the basis of application, the Europe amniotic membrane market is segmented into surgical wounds, ophthalmology, and others. In 2022, the surgical wounds segment is expected to dominate the market due to the increasing number of trauma and burn injuries due to road traffic accidents (RTA).
• On the basis of end-user, the Europe amniotic membrane market is segmented into hospitals, ambulatory surgical centers, research institutes and academic institutes, and specialty clinics. In 2022, the hospitals segment is expected to dominate the market as the number of burn injuries and trauma is increasing, and they require immediate surgery.

Europe Amniotic Membrane Market Country Level Analysis

Europe amniotic membrane market is analyzed and market size information is on basis of product, application and end-user.

The countries covered in the Europe amniotic membrane market report are Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and Rest of Europe.

Germany is expected to grow with the most promising growth rate in the forecast period of 2022 to 2029 due to the rapidly increasing patient population and advancements in technology. France is the second dominating country due to the growing healthcare infrastructure. While, the U.K. stands for the third position in the Europe amniotic membrane market due to the increasing number of surgeries for amniotic membrane transplantation.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Rising Adaptation of Amniotic Membrane Transplantation in Ophthalmology is Creating New Opportunities for Players in the Europe Amniotic Membrane Market

Europe amniotic membrane also provides you with detailed market analysis for every country growth in aesthetic industry with cold sore treatment sales, impact of advancement in the amniotic membrane and changes in regulatory scenarios with their support for the Europe amniotic membrane market. The data is available for historic period 2011 to 2019.  

Competitive Landscape and Europe Amniotic Membrane Market Share Analysis

Europe amniotic membrane market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe amniotic membrane market.

Some of the major companies which are dealing in the market are Smith & Nephew plc, Stryker, Katena Products. Inc., The Electrospinning Company, NuVision Biotherapies Ltd, Amnio Technology, LLC, Integra LifeSciences, Organogenesis, Inc, MIMEDX, Applied Biologics, Skye Biologics Holdings, LLC and Amniox Medical, Inc.

• According to the Eurostat, in 2016, the number of road accident fatalities per million inhabitants was 50.5 in European Union.
• According to the Europe Transport Safety Council, in 2020, the number of road deaths per million inhabitants was 42 in European Union.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the Europe amniotic membrane market which also provides the benefit for organisation to improve their offering for amniotic membrane.

SKU-67472